Sterilization as the interface between product, process and evidence
For many medical devices and packaging systems, sterilization is a critical interface between product design, process definition and regulatory evidence. This is where microbiological data, validation strategy and documentation requirements must be considered together.
In regulated environments, sterilization and microbiological monitoring are closely linked to product safety, process robustness and compliance. Their relevance goes far beyond the execution of a single test or validation step.
The complexity increases when factors such as bioburden, endotoxins, sterilization dose, material behavior and documentation requirements need to be assessed in relation to one another. Dose audits, dose mapping and process validations can therefore only be evaluated meaningfully within the overall context of the product and its intended process.
Früh has expanded its capabilities in this field with modular sterilization and monitoring services. These include support for gamma, X-ray, EtO and steam validations, as well as assistance with planning, coordination, execution and audit-ready documentation.
The focus is on creating a structured framework for tasks that are often technically demanding, resource-intensive and time-critical. This helps to improve traceability, reduce interface complexity and align project-specific requirements more effectively.
